Rewriting E. coli’s Genetic Code

Researchers use directed evolution to create a bacterial strain that substitutes a synthetic base for thymine.

Written bySabine Louët
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

E. coli cells that use synthetic base 5-chlorouracile in place of thymineIG-CEA

Using a new automated system for placing strong selective pressure on cultured bacteria, a team of European scientists has evolved a new strain of E. coli that almost completely lacks thymine—one of the four bases of the DNA alphabet. Instead, the bacteria contain the structurally similar synthetic base, 5-chlorouracil.

The results, published in a recent issue of Angewandte Chemie International Edition, suggest a new way for incorporating unnatural elements into living organisms—a technical challenge in synthetic biology that has yet to see industrial applications.

“They have shown that they have a good control of the evolution process,” said molecular geneticist George Church of Harvard University, who was not involved in the research. “Darwin would be very proud!”

Organisms evolve as a result of randomly-occurring mutations ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies